Axon Enterprise (AXON) Stock After 45% Slide Can The Growth Story Justify Today’s Price
Axovant Sciences Ltd AXON | 0.00 |
- If you are trying to work out whether Axon Enterprise stock is genuinely attractive at current levels, the key question is whether the price still matches the story behind the business.
- The stock last closed at US$423.01, with returns that include a decline of 5.5% over the past week, a gain of 5.9% over the past month, a decline of 24.9% year to date, and a decline of 45.1% over the past year, while still showing a gain of 114.1% over three years and 154.9% over five years.
- Recent price moves sit against a backdrop of ongoing interest in Axon Enterprise's role in public safety technology and its broader ecosystem of hardware, software and cloud services. Investors have been weighing that long term story against current market sentiment and risk appetite. That helps explain the mix of shorter term declines and longer term gains.
- Axon Enterprise currently has a valuation score of 1 out of 6, reflecting that it screens as undervalued on only one of six standard checks. The sections that follow will compare different valuation methods before finishing with a broader framework for thinking about what the stock might really be worth.
Axon Enterprise scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
Approach 1: Axon Enterprise Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model estimates what Axon Enterprise stock might be worth by projecting future cash flows and then discounting those back to today to reflect time and risk. It is essentially asking what those future dollars are worth in today’s terms.
For Axon Enterprise, the latest reported Free Cash Flow is about $28.7 million. Analysts provide cash flow estimates out to 2028, with Simply Wall St extrapolating further to build out a 2 Stage Free Cash Flow to Equity model. Within that model, projected Free Cash Flow for 2035 is $2.1 billion, with intermediate years ranging from $432.2 million in 2026 to $1.9 billion in 2034.
Discounting this stream of cash flows back to today produces an estimated intrinsic value of roughly $385.50 per share. Compared with the recent share price of $423.01, the model suggests Axon Enterprise is about 9.7% overvalued. This difference sits within a band that many investors may still view as broadly in line with fundamentals.
Result: ABOUT RIGHT
Axon Enterprise is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.
Approach 2: Axon Enterprise Price vs Sales
For a company like Axon Enterprise, where investors often focus on the scale and potential of its revenue base, the P/S ratio can be a useful way to think about valuation. It relates the stock price to the revenue generated per share, which can be helpful when earnings are not the primary focus.
Expectations for future growth and the level of risk usually drive what looks like a normal or fair P/S multiple for a stock. Higher perceived growth or lower risk can justify a higher multiple, while lower growth or higher risk can point to a lower one.
Axon Enterprise currently trades on a P/S of 11.43x. That sits above the Aerospace & Defense industry average P/S of 5.68x and the peer average of 9.26x. Simply Wall St’s proprietary Fair Ratio for Axon Enterprise is 15.28x. This is the P/S level it estimates based on factors such as the company’s growth profile, profit margins, risk characteristics, industry and market cap. Because it blends these company specific inputs, the Fair Ratio can offer a more tailored reference point than a simple comparison with peers or the broad industry. On this basis, Axon Enterprise’s current P/S of 11.43x screens below the Fair Ratio of 15.28x, indicating that the stock appears undervalued on this measure.
Result: UNDERVALUED
P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Upgrade Your Decision Making: Choose your Axon Enterprise Narrative
Earlier the idea of a better way to think about valuation was raised, and that is where Narratives come in. They give you a simple way to turn your view of Axon Enterprise into a story that links assumptions about future revenue, earnings and margins to a Fair Value that can be compared with today’s price. All of this happens within the Narratives tools on Simply Wall St’s Community page, where each Narrative updates as new news or earnings arrive. For example, one Axon Enterprise Narrative currently anchors on a Fair Value of about US$606.83 per share, while another sits much higher at about US$825.00. This illustrates how different investors can look at the same company and reach very different, but clearly quantified, conclusions about whether the stock looks expensive or attractive at its latest price.
For Axon Enterprise, here are previews of two leading Axon Enterprise Narratives to make comparison easier:
Fair value: US$662.04 per share
Implied upside versus the last close of US$423.01: about 36.1% below this fair value
Revenue growth assumption: 28.14% a year
- Focuses on Axon Enterprise as an AI enabled public safety platform with a growing base of premium SaaS bundles, recurring revenue and higher margin software and services.
- Highlights catalysts such as adoption of products like TASER 10, Axon Body 4, Draft One and Dedrone, alongside wider international expansion and a larger addressable market.
- Anchors on analyst assumptions for faster revenue growth, modest margin expansion and a higher future P/E multiple, while flagging risks around regulation, government budgets, competition and costs.
Fair value: US$420.19 per share
Implied downside versus the last close of US$423.01: about 0.7% above this fair value
Revenue growth assumption: 26.73% a year
- Frames Axon Enterprise as exposed to margin pressure from commoditisation of AI hardware and software, tighter data privacy rules and higher compliance and operating costs.
- Emphasises risks tied to dependence on government budgets, procurement cycles and law enforcement funding priorities, as well as sector wide multiple compression.
- Uses more cautious assumptions for margins and earnings, alongside a higher required P/E multiple, to arrive at a fair value that sits close to the recent share price and below consensus targets.
If you want to see how other investors are joining the dots between these Axon Enterprise narratives, risks and valuation signals over time, it is worth reviewing the wider range of community views and tracking how the story shifts with each new update, To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Axon Enterprise on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves..
Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
